scholarly article | Q13442814 |
P2093 | author name string | Peng Lu | |
Nan Wu | |||
Jie Liu | |||
Wen-Jie Song | |||
Liang Zhou | |||
Bai Ruan | |||
Ke-Feng Dou | |||
Zheng Dang | |||
Wei-Hua Xu | |||
P2860 | cites work | Global cancer statistics | Q22241238 |
Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia | Q24539231 | ||
A microRNA expression signature of human solid tumors defines cancer gene targets | Q24541455 | ||
Circulating microRNAs as stable blood-based markers for cancer detection | Q24652098 | ||
Mel-18 acts as a tumor suppressor by repressing Bmi-1 expression and down-regulating Akt activity in breast cancer cells | Q24654211 | ||
Bmi-1 is a target gene for SALL4 in hematopoietic and leukemic cells | Q24669757 | ||
Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis | Q24798477 | ||
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
MicroRNA expression profiles classify human cancers | Q28032481 | ||
Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells | Q28201183 | ||
Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths | Q28241157 | ||
Both p16 and p21 families of cyclin-dependent kinase (CDK) inhibitors block the phosphorylation of cyclin-dependent kinases by the CDK-activating kinase | Q28294919 | ||
A microRNA component of the p53 tumour suppressor network | Q28305330 | ||
MicroRNAs in Cancer | Q29615539 | ||
The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs | Q29615910 | ||
Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells | Q29618944 | ||
The cyclin-dependent kinase inhibitor p21 is a crucial target for histone deacetylase 1 as a regulator of cellular proliferation. | Q33648852 | ||
Downregulation of metastasis suppressor 1(MTSS1) is associated with nodal metastasis and poor outcome in Chinese patients with gastric cancer | Q33659482 | ||
The homeodomain-containing proteins: an update on their interacting partners | Q33790697 | ||
miRNA-135a promotes breast cancer cell migration and invasion by targeting HOXA10. | Q34206812 | ||
Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer | Q34570526 | ||
Expression profiling identifies microRNA signature in pancreatic cancer | Q34588109 | ||
MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma | Q34604367 | ||
Clinicopathological significance of missing in metastasis B expression in hepatocellular carcinoma. | Q34620262 | ||
MicroRNAs accurately identify cancer tissue origin | Q34764379 | ||
Self-renewal of hematopoietic and leukemic stem cells: a central role for the Polycomb-group gene Bmi-1 | Q35557266 | ||
Regulation of JAK-STAT signalling in the immune system | Q35605437 | ||
A chemical method for fast and sensitive detection of DNA synthesis in vivo | Q36497275 | ||
The c-Myc target gene network | Q36564217 | ||
Principles and effects of microRNA-mediated post-transcriptional gene regulation. | Q36617803 | ||
MicroRNA involvement in hepatocellular carcinoma | Q37361575 | ||
MicroRNAs in cancer: small molecules with a huge impact | Q37474280 | ||
Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma | Q38331260 | ||
Tumor-suppressive microRNA-135a inhibits cancer cell proliferation by targeting the c-MYC oncogene in renal cell carcinoma | Q39240032 | ||
MiR-135a promotes growth and invasion of colorectal cancer via metastasis suppressor 1 in vitro | Q39270381 | ||
MiR-135a targets JAK2 and inhibits gastric cancer cell proliferation | Q39400620 | ||
MiR-135a functions as a selective killer of malignant glioma. | Q39433440 | ||
MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis | Q39454748 | ||
MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma | Q39480218 | ||
Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis | Q39619751 | ||
The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS | Q39673083 | ||
Bmi-1 is related to proliferation, survival and poor prognosis in pancreatic cancer | Q39709881 | ||
Knockdown of Bmi-1 impairs growth and invasiveness of human gastric carcinoma cells | Q39790904 | ||
Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma. | Q39814632 | ||
Metastasis suppressor 1 (MTSS1) demonstrates prognostic value and anti-metastatic properties in breast cancer | Q39867235 | ||
MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease | Q39950193 | ||
Downregulation of BMI-1 enhances 5-fluorouracil-induced apoptosis in nasopharyngeal carcinoma cells | Q39985930 | ||
Antisense RNA-mediated suppression of Bmi-1 gene expression inhibits the proliferation of lung cancer cell line A549. | Q40081403 | ||
Effects of miR-135a on HOXA10 expression, proliferation and apoptosis of ovarian cancer cells | Q45720756 | ||
Construction of antisense Bmi-1 expression plasmid and its inhibitory effect on K562 cells proliferation. | Q46698419 | ||
Identification of metastasis-related microRNAs in hepatocellular carcinoma. | Q51897320 | ||
BMI-1 is highly expressed in M0-subtype acute myeloid leukemia. | Q53355262 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | microRNA | Q310899 |
adenocarcinoma | Q356033 | ||
pancreatic ductal carcinoma | Q8263002 | ||
pancreatic ductal adenocarcinoma | Q18555956 | ||
P304 | page(s) | 733-745 | |
P577 | publication date | 2014-06-24 | |
P1433 | published in | International Journal of Biological Sciences | Q6051326 |
P1476 | title | MicroRNA-135a inhibits cell proliferation by targeting Bmi1 in pancreatic ductal adenocarcinoma | |
P478 | volume | 10 |